Dopamine D3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep
- 1 September 1999
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 10 (14) , 3111-3118
- https://doi.org/10.1097/00001756-199909290-00043
Abstract
We have recently demonstrated that local perfusion of dopaminergic D2/D3 agonists into the ventral tegmental area (VTA) significantly aggravates cataplexy and increases sleep in narcoleptic Dobermans. We further assessed the roles of the mesostriatal dopaminergic system and found that local perfusion of quinpirole and 7-OH-DPAT into the substantia nigra (SN) significantly aggravated cataplexy, while perfusion of a D2/D3 antagonist significantly reduced cataplexy. Neither a D1 agonist nor a D1 antagonist modified cataplexy. SN perfusion of quinpirole did not significantly modify sleep, while VTA perfusion significantly increased the drowsy state. Although autoregulation of the VTA and SN dopaminergic neurons are involved in the regulation of cataplexy, both structures have distinct roles for the regulation of sleep.Keywords
This publication has 3 references indexed in Scilit:
- Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsyJournal of Neuroscience, 1995
- Dopamine D2 mechanisms in canine narcolepsyJournal of Neuroscience, 1991
- Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycleJournal of Neuroscience, 1981